If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

Rule 8.4 Disclosure

10 Mar 2009 11:20

RNS Number : 6127O
W.H. Ireland Group PLC
10 March 2009
 



10 March 2009

WH Ireland Group PLC ("WH Ireland")

Rule 8.4 Disclosure

As referred to in the announcement released by WH Ireland and Blue Oar PLC ("Blue Oar") on 2 March 2009, the irrevocable commitment received by WH Ireland from Evolve Capital PLC ("Evolve") (the "Evolve Undertaking") to vote in favour of (or accept) the possible offer by WH Ireland for Blue Oar (the "Possible Offer") in respect of Evolve's entire holding of Blue Oar shares (representing approximately 64.9 per cent. of the existing issued share capital of Blue Oar) ceased to be binding if, inter alia, an announcement of a firm intention to make an offer under Rule 2.5 of the City Code was not made by 12 noon on 9 March 2009.

WH Ireland and Blue Oar further announced on 9 March 2009 that discussions were well advanced and ongoing between the parties and that a further announcement would be made in due course.

As the Evolve Undertaking has now ceased to be binding, WH Ireland announces it no longer has a disclosable interest in the securities of Blue Oar under the provisions of Rule 8.4 of the City Code.

Enquiries:

WH Ireland

Richard Ford

Tel: 020 7220 0475

Oriel Securities Ltd

Tom Durie

Jonathan Walker

Tel: 020 7710 7600

Biddicks (Financial PR to WH Ireland)

Zoe Biddick

Tel: 020 7448 1000

Dealing Disclosure Requirements

The disclosure requirements are set out in more detail in Rule 8 of the Code. In particular, under the provisions of Rule 8.3 of the Code, if any person is, or becomes, 'interested' (directly or indirectly) in one per cent. or more of any class of 'relevant securities' of Blue Oar or WH Ireland, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 p.m. (London time) on the Business Day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the offer period otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Blue Oar or WH Ireland, they will be deemed to be a single person for the purpose of Rule 8.3 of the Code.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Blue Oar or WH Ireland by WH Ireland or Blue Oar, or by any of their respective 'associates' (within the meaning of the Code), must also be disclosed by no later than 12.00 p.m. (London time) on the Business Day following the date of the relevant transaction.

A disclosure table giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Panel's website at www.thetakeoverpanel.org.uk

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities. 

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8 of the Code, you should consult the Panel.

If you are in any doubt as to the application of Rule 8 to you, please contact an independent financial adviser authorised under the Financial Services and Markets Act 2000, consult the Panel's website at www.thetakeoverpanel.org.uk or contact the Panel on telephone number +44 (020) 7638 0129; fax: +44 (020) 7236 7013.

This Announcement does not constitute, or form part of, an offer or invitation to purchase any securities.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPMGGMFMGVGLZM
Date   Source Headline
18th Dec 20197:05 amRNSIssue of Options
18th Dec 20197:00 amRNSDirectorate Change - Update
21st Nov 201910:58 amRNSResult of General Meeting
8th Nov 20194:00 pmRNSConfirmation of General Meeting
7th Nov 20197:00 amRNSWH Ireland CIB announces three new appointments
6th Nov 20194:20 pmRNSResult of Placing
6th Nov 20197:10 amRNSProposed Placing
6th Nov 20197:05 amRNSInterim Results
6th Nov 20197:00 amRNSBoard Appointments
23rd Oct 20197:00 amRNSHolding(s) in Company
23rd Oct 20197:00 amRNSHolding(s) in Company
4th Oct 20197:00 amRNSBoard Changes
27th Sep 20197:00 amRNSDirectorate Change - Update
12th Sep 20192:53 pmRNSResult of AGM
20th Aug 20197:00 amRNSDirectorate Change & Updated Notice of AGM
2nd Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSFinal Results & Notice of AGM
23rd Jul 20197:00 amRNSBoard Appointment
28th Jun 201912:13 pmRNSIssue of Options
25th Jun 20199:19 amRNSDirector/PDMR Shareholding
24th Jun 20197:00 amRNSDirectorate Change Update
13th May 20192:26 pmRNSDirectorate Change Update
24th Apr 20197:00 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
4th Apr 20197:00 amRNSDirector/PDMR Shareholding
29th Mar 20197:00 amRNSBoard appointment
26th Mar 20194:44 pmRNSHolding(s) in Company
26th Mar 201910:32 amRNSHolding(s) in Company
21st Mar 20191:59 pmRNSResult of General Meeting
13th Mar 201910:59 amRNSHolding(s) in Company
5th Mar 20194:21 pmRNSResult of Placing and Notice of General Meeting
5th Mar 20197:00 amRNSProposed Placing
6th Feb 20197:00 amRNSDirectorate Changes and Trading Update
21st Dec 20187:00 amRNSDirectorate Change Update
12th Dec 20187:00 amRNSAppointment of New Head of Wealth Management
28th Nov 20187:00 amRNSDirectorate Change
28th Nov 20187:00 amRNSInterim Results
17th Oct 20189:42 amRNSConfirmation of Appointment of CEO
12th Oct 20187:00 amRNSHolding(s) in Company
11th Oct 20182:52 pmRNSHolding(s) in Company
11th Oct 20181:29 pmRNSHolding(s) in Company
10th Oct 20185:10 pmRNSHolding(s) in Company
9th Oct 201811:07 amRNSResult of General Meeting
27th Sep 201812:36 pmRNSResult of AGM & Confirmation of Directorate Change
24th Sep 20184:45 pmRNSHolding(s) in Company
24th Sep 20184:43 pmRNSHolding(s) in Company
20th Sep 201810:36 amRNSShareholder Update, Placing and Notice of GM
20th Sep 201810:35 amRNSHolding(s) in Company
20th Sep 201810:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.